Who Owns Nuvectis Pharma, Inc. (NVCT)?Hedge Fund & Institutional Holders
Institutional Holders
50
as of Q4 2025
Total Institutional Value
$5.4704049400029415e+82T
% of Float Held
—
QoQ Change in Holders
+12 / -8
Price History
NVCT — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| IRIDIAN ASSET MANAGEMENT LLC/CT | New Position | +586K | +$4.4M |
| OPPENHEIMER & CO INC | New Position | +74K | +$555K |
| FORBES J M & CO LLP | New Position | +59K | +$445K |
| Austin Wealth Management, LLC | New Position | +20K | +$178K |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | New Position | +13K | +$98K |
| NBC SECURITIES, INC. | New Position | +3K | +$22K |
| Spire Wealth Management | New Position | +300 | +$2K |
| CIBC Private Wealth Group LLC | New Position | +15K | +$0 |
| Bank of New York Mellon Corp | New Position | +32K | +$0 |
| CWM, LLC | New Position | +33 | +$0 |
| NEW YORK STATE COMMON RETIREMENT FUND | New Position | +5K | +$0 |
| AMALGAMATED BANK | New Position | +486 | +$0 |
| Sterling Capital Management LLC | Increased | +53 | +$-187K |
| FMR LLC | Increased | +7K | +$-403K |
| GAMMA Investing LLC | Increased | +83 | +$-529K |
NVCT — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | Decreased | -19K | -$271.9M |
| RENAISSANCE TECHNOLOGIES LLC | Closed Position | -43K | -$257.7M |
| ROYAL BANK OF CANADA | Decreased | -30K | -$186.0M |
| JANE STREET GROUP, LLC | Closed Position | -26K | -$158.2M |
| UBS Group AG | Decreased | -17K | -$153.3M |
| TWO SIGMA INVESTMENTS, LP | Closed Position | -18K | -$111.0M |
| XTX Topco Ltd | Closed Position | -15K | -$89.5M |
| RHUMBLINE ADVISERS | Decreased | -3K | -$68.2M |
| MARSHALL WACE, LLP | Closed Position | -11K | -$64.4M |
| Tower Research Capital LLC (TRC) | Decreased | -2K | -$23.2M |
| CITIGROUP INC | Decreased | -160 | -$3.3M |
| EverSource Wealth Advisors, LLC | Closed Position | -76 | -$458K |
| PNC FINANCIAL SERVICES GROUP, INC. | Decreased | -32 | -$331K |
| Arax Advisory Partners | Closed Position | -38 | -$229K |
| GSA CAPITAL PARTNERS LLP | Closed Position | -23K | -$141K |
Top Institutional Holders(Q4 2025)
NVCT Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 48 | $24.2M | +4 |
| Q3 2025 | 44 | $18.5B | +3 |
| Q2 2025 | 41 | $21.3B | +8 |
| Q1 2025 | 33 | $19.7B | +3 |
| Q4 2024 | 30 | $2.0T | +1 |
| Q3 2024 | 29 | $4.4T | -8 |
| Q2 2024 | 37 | $4.6T | +0 |
| Q1 2024 | 37 | $7.4T | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 50 institutional investors hold NVCT (Nuvectis Pharma, Inc.). The largest holder is VANGUARD GROUP INC with $5.5M in shares. This quarter, 12 institutions opened new positions and 8 closed their positions.
Frequently Asked Questions
How many hedge funds own NVCT?
As of Q4 2025, 50 institutional investors report holding NVCT (Nuvectis Pharma, Inc.) in their 13F filings.
Who is the largest institutional holder of NVCT?
The largest institutional holder of NVCT is VANGUARD GROUP INC with $5.5M in shares.
Is institutional ownership of NVCT increasing or decreasing?
This quarter, 12 institutions opened new positions in NVCT and 8 closed their positions.